Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation

Posted by D. Daniel Sokol Ernst R. Berndt, MIT Sloan School of Management and Murray Aitken, Healthcare Insight, IMS Health observe Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation. ABSTRACT:…

Read more detail on Recent Antitrust Posts –

This entry was posted in Antitrust - Competition law and tagged , , , , , , , , , , . Bookmark the permalink.

Leave a Reply